Peter Weeke, MD

Peters interest is in pharmacogenetics and personalized medicine. Ongoing projects aim to delineate the genetic basis of adverse drug events such as drug induced long QT syndrome and Torsades des pointes using next-generation sequencing methods.

Publications

Examining Rare and Low-Frequency Genetic Variants Previously Associated With Lone or Familial Forms of Atrial Fibrillation in an Electronic Medical Record System

Citations